Status:
COMPLETED
Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy
Lead Sponsor:
ProSight
Collaborating Sponsors:
Tel-Aviv Sourasky Medical Center
Conditions:
Prostate Cancer
Eligibility:
MALE
45+ years
Brief Summary
The purposes of this study are to: i) confirm and improve the accuracy of the correlation between levels of Zinc in prostate tissue and the grade of prostate cancer in that tissue as determined throug...
Eligibility Criteria
Inclusion
- Elevated PSA, \>10ng/mL
- Subject underwent primary and at least one secondary (repeat) prostate biopsy with negative diagnosis
- Subject directed at saturated trans-perineal biopsy
Exclusion
- Subject was under Zn supplement nutrition treatment
Key Trial Info
Start Date :
February 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01915316
Start Date
February 1 2014
End Date
February 1 2015
Last Update
October 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, 64239